Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Biochemical Pharmacology|March 28, 2015
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIsElena Dale, Benny Bang-Andersen, Connie SánchezCurrent Topics in Medicinal Chemistry|September 4, 2014
Chemical biology of mGlu4 receptor activation: dogmas, challenges, strategies and opportunitiesXinyan Huang, Elena Dale, Robbin M Brodbeck, et al.Glia|April 29, 2016
KCa 3.1-a microglial target ready for drug repurposing?Elena Dale, Roland G W Staal, Claudia Eder, et al.Neuropharmacology|May 29, 2014
Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian actionPaolo Gubellini, Christophe Melon, Elena Dale, et al.ACS Chemical Neuroscience|March 10, 2015
Serotonergic Regulation of Prefrontal Cortical Circuitries Involved in Cognitive Processing: A Review of Individual 5-HT Receptor Mechanisms and Concerted Effects of 5-HT Receptors Exemplified by the Multimodal Antidepressant VortioxetineSteven C Leiser, Yan Li, Alan L Pehrson, et al.Frontiers in Neuroscience|September 1, 2015
A critical evaluation of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1)'s putative role in regulating dendritic plasticity, cognitive processes, and mood in animal models of depressionYan Li, Alan L Pehrson, Jessica A Waller, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 6, 2016
Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical reviewKristian Gaarn du Jardin, Heidi Kaastrup Müller, Betina Elfving, et al.Frontiers in Pharmacology|November 11, 2017
Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with EscitalopramShreaya Chakroborty, Thomas R Geisbush, Elena Dale, et al.European Journal of Pharmacology|August 10, 2014
Treatment of cognitive dysfunction in major depressive disorder--a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetineAlan L Pehrson, Steven C Leiser, Maria Gulinello, et al.Journal of Psychopharmacology (Oxford, England)|August 15, 2014
Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampusElena Dale, Hong Zhang, Steven C Leiser, et al.Pageof 3